Shares VERACYTE, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 25th, 2013 • Veracyte, Inc. • Services-medical laboratories • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) and Leerink Swann LLC (“Leerink”), together as representatives of the several Underwriters (as defined below), propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Veracyte, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley and Leerink (the “Underwriters”), of shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”).
